Immunoallergology Unit, Department of Clinical and Experimental Medicine, Pisa University, Pisa, Italy.
Otolaryngology, Audiology, and Phoniatric Operative Unit, Department of Surgical, Medical, Molecular Pathology, and Critical Care Medicine, Pisa, Italy.
Int Arch Allergy Immunol. 2022;183(7):770-777. doi: 10.1159/000522255. Epub 2022 Mar 31.
Chronic rhinosinusitis with nasal polyps (CRSwNP) is a predominantly type 2 inflammation-mediated disease of the nasal mucosa and paranasal sinuses that often coexists with asthma. The role of atopy in the development and severity of CRSwNP is still a controversial issue.
The aim of our study was to propose a systematic allergy workup to identify atopic patients in the context of CRSwNP and to characterize their allergen sensitization profile (sources/molecules).
Patients with a diagnosis of CRSwNP (n = 97) were studied in the otorhinolaryngologist and allergy settings. Demographic and clinical data were collected for each patient. Different allergen sensitization profiles (sources/molecules) were evaluated in atopic CRSwNP patients by using component-resolved diagnosis (CRD).
In our cohort of patients, the CRSwNP was frequently diagnosed during adulthood with significant impact on health-related quality of life. Asthma and atopy were the most common comorbidities with a prevalence of asthma in the atopic group. In CRSwNP patients sensitized to grass pollens and/or to house dust mites, the CRD analysis revealed a prevalence of sensitization to species-specific allergens of Phleum pratense (Phl p1, Phl p2, and Phl p5) or Dermatophagoides pteronyssinus (Der p1 and Der p2) rather than to cross-reactive ones.
To define the allergen sensitization profile in atopic CRSwNP patients by CRD, it may be useful to better characterize type 2 inflammation, thus providing a personalized endotype-driven treatment.
伴有鼻息肉的慢性鼻-鼻窦炎(CRSwNP)是一种主要由 2 型炎症介导的鼻腔和鼻窦黏膜疾病,常与哮喘并存。特应性在 CRSwNP 的发展和严重程度中的作用仍是一个有争议的问题。
我们的研究旨在提出一种系统的过敏检测方法,以确定 CRSwNP 患者中的特应性患者,并描述其过敏原致敏谱(来源/分子)。
在耳鼻喉科和过敏科环境中研究了诊断为 CRSwNP 的 97 例患者。为每位患者收集了人口统计学和临床数据。通过使用成分分辨诊断(CRD)评估特应性 CRSwNP 患者的不同过敏原致敏谱(来源/分子)。
在我们的患者队列中,CRSwNP 常在成年期诊断,对健康相关生活质量有重大影响。哮喘和特应性是最常见的合并症,特应性组哮喘的患病率较高。在对草花粉和/或屋尘螨过敏的 CRSwNP 患者中,CRD 分析显示对 Phleum pratense(Phl p1、Phl p2 和 Phl p5)或 Dermatophagoides pteronyssinus(Der p1 和 Der p2)的特异性过敏原的致敏率较高,而不是交叉反应性过敏原。
通过 CRD 确定特应性 CRSwNP 患者的过敏原致敏谱,可能有助于更好地描述 2 型炎症,从而提供个性化的基于表型的治疗。